Skip to content

Veracyte VCYT Change in AR

Change in AR at other companies

Guardant Health logo
Guardant HealthGH
-$942K-115%
Natera, Inc. logo
Natera, Inc.NTRA
$121.07M+2,876%
Revvity logo
RevvityRVTY
-$61.55M-239%
Labcorp Holdings logo
Labcorp HoldingsLH
$187.9M+10.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
$180M+78.2%
Agilent Technologies logo
Agilent TechnologiesA
$18M-40.0%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's change in AR?
Veracyte (VCYT) reported change in AR of $5.57M in Q1 2026.
How has Veracyte's change in AR changed year-over-year?
Veracyte's change in AR decreased by 21.1% year-over-year, from $7.05M to $5.57M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.